99.3% PURITY LOT VL-2753-A KLOW
A multi-peptide regenerative research blend supplied as an 80 mg total lyophilized vial for laboratory research into tissue recovery, repair, and regeneration.
- 1 × KLOW 80mg vial
- Tamper-evident flip-off cap
- Batch-tested for purity (≥99%)
- Lyophilized for stability during shipping
- Bacteriostatic water (3 mL)
About this compound
A multi-peptide regenerative research blend supplied as an 80 mg total lyophilized vial for laboratory research into tissue recovery, repair, and regeneration.
- 80 mg total lyophilized peptide blend per vial
- Multi-peptide regenerative / recovery research blend
- Synthetic peptide blend, ≥99% purity
- Studied for tissue repair, recovery and regeneration
Why the lot matters
- Synthesized and tested per lot, never as a production-run average
- Certificate of Analysis published before the lot goes on sale
- Independent lab, contractually separate from manufacturing
What "research use only" means
This product is sold exclusively for in-vitro laboratory research. It is not evaluated by any medicines agency and is not intended for human or animal administration, diagnosis, treatment, or prevention of disease.
Technical data
Current lot snapshot
Shipping
Reported use in research
KLOW is a multi-peptide research blend formulated to combine several regenerative peptides within a single lyophilized vial for laboratory study of tissue recovery. As a blend, it is investigated for the way its constituent peptides may act through complementary pathways associated with repair and regeneration research. It is studied in preclinical and in vitro models for processes such as angiogenesis, cell migration, extracellular-matrix support, and modulation of inflammatory signaling. The precise formulation is proprietary, and its combined mechanism has not been fully characterized in published research.
Reported findings
Research into regenerative peptide combinations reports that pairing agents with distinct but overlapping activities may support faster tissue recovery than single peptides in animal and cell-based models. Reported observations include improved blood flow, enhanced cellular migration toward injury sites, and support for the structural repair of connective and soft tissue. As a proprietary multi-peptide blend, KLOW has not been characterized as a whole in controlled clinical research, and the available evidence for its combined activity remains largely preclinical. These properties have positioned regenerative blends as a subject of interest in recovery and tissue-repair research models.
Handling & safety
As a multi-peptide research blend, KLOW’s combined safety profile has not been fully characterized in research models, and controlled human clinical data are not available. Individual regenerative peptides of this class have generally shown favorable tolerability in animal research, but interactions within the blend and long-term effects remain poorly defined. It should be handled only under appropriate laboratory conditions using standard precautions for research chemicals. This material is not intended to diagnose, treat, or prevent any condition.
Reconstitution
Recommended ratio
- 3 mL of bacteriostatic water per 80 mg vial
- Equivalent to 26.67 mg/mL (i.e. 2.67 mg per 10 units on a 100 U insulin syringe)
- Remove the plastic flip-off lid from the vial.
- Disinfect the rubber stoppers with alcohol wipes.
- Inject the diluent slowly down the inner wall of the vial to avoid foaming.
- Gently swirl the vial (never shake). Let it dissolve for about 10 minutes.
Storage
Unopened / before reconstitution
- Store at a stable temperature.
- Stable for 24 months.
- For long-term storage (2+ years), store at -20 °C.
Reconstituted solution
- Must be kept refrigerated.
- Avoid exposure to light and excessive heat.
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with - | PASS |
| Purity | HPLC (area %) | 99.3% | PASS |
| Net peptide content | Gravimetric | 80.24 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
3RD-PARTY LAB
| Parameter | Method | Result | Status |
|---|---|---|---|
| Identity confirmation | Mass spectrometry | Consistent with - | PASS |
| Purity | HPLC (area %) | 99.2% | PASS |
| Net peptide content | Gravimetric | 80.08 mg | PASS |
| Appearance | Visual | White to off-white lyophilized powder | PASS |
| Residual solvents | GC headspace | Within limits | PASS |
| Microbial screening | Sterility panel | No growth detected | PASS |
| Lot | Filled | Purity | Report | Status | |
|---|---|---|---|---|---|
| VL-2753-A | Jul 2026 | 99.3% | TR-88225 | Active | |
| VL-2734-B | May 2026 | 99.2% | TR-88172 | Sold out |
